NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a supplier of Phenylacetylglutamine (CAS 28047-15-6), a compound of increasing interest in the scientific community due to its diverse biological functions and potential as a key biomarker.

Phenylacetylglutamine is a metabolite found in humans, primarily formed through the conjugation of phenylacetate with glutamine. Its presence is significant in the body's management of nitrogenous waste, acting as an alternative route for excretion, especially in cases of urea cycle dysfunction. This makes it crucial for understanding and managing urea cycle disorders, highlighting its role in phenylacetylglutamine urea cycle support.

A significant area of research involves Phenylacetylglutamine as a biomarker for metabolic age. The levels of this compound in urine have been observed to increase with age, providing researchers with a valuable tool to assess biological aging and its related physiological changes. The study of phenylacetylglutamine in human urine offers a novel perspective on aging processes.

Furthermore, Phenylacetylglutamine is gaining recognition as a potential indicator for kidney health. Research suggests its utility as a phenylacetylglutamine kidney disease indicator, with elevated concentrations potentially signaling early signs of chronic kidney disease. This application is vital for early diagnosis and intervention strategies.

The compound is also being explored for its role in cardiovascular health, linking it as a cardiovascular health metabolite. Its presence and concentration may offer insights into cardiovascular risk factors and disease progression.

As a high-quality chemical supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that researchers have access to Phenylacetylglutamine for critical studies in metabolic health, aging, renal function, and pharmaceutical development. Our commitment to purity and reliability supports the ongoing discoveries surrounding this versatile metabolite.